Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesGelStat Corp

GelStat Corp

Technology Software - Infrastructure
PortfolioPortfolio WatchlistWatchlist
Company price
0.0003 USD 0.00(0%)
Last update at 2026-11-10T21:00:00Z
VOLUME
3449
Market Cap
1.12M

Momentum Score

…

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation was founded in 2002 and is headquartered in Palm City, Florida.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

GelStat Corp (GSAC.US) is an OTC Pink‑listed micro‑cap company for which publicly available disclosures about business activities and products are minimal. Long‑term value may depend on successful development or commercialization of its offerings, obtaining regulatory clearances and distribution or licensing agreements, which could support revenue growth and licensing upside.
Major risks include very low liquidity, reliance on external financing with likely dilution, an unproven commercial track record, and regulatory and execution uncertainty that could impair value.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
0.36M
Revenue Per Share
-
Gross Profit TTM
0.26M
Debt / Equity
-0.68
ROE
-26.51%
Net Debt
0.85M
ROCE
50.71%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -0.33M -0.37M -0.21M -0.76M -
Net income -0.33M -0.37M -0.21M -0.76M -
Selling general administrative - 0.17M 0.02M 0.05M -
Selling and marketing expenses - 0.31M 0.27M 0.47M -
Gross profit -0.13M 0.23M 0.13M -0.41M -
Ebit -0.24M -0.28M -0.16M -0.59M -0.31M
Ebitda -0.21M -0.25M -0.15M 0.01M -
Depreciation and amortization 0.03M 0.03M 0.01M 0.60M -
Operating income -0.24M -0.28M -0.17M -0.60M -
Other operating expenses 0.51M 0.63M 0.32M 0.60M -
Interest expense 0.08M 0.09M 0.04M 0.02M 0.00M
Income tax expense - - 0.00M -0.45M -
Total revenue 0.27M 0.35M 0.15M 0.00M -
Total operating expenses 0.11M 0.51M 0.30M 0.19M -
Cost of revenue 0.40M 0.12M 0.02M 0.41M -
Total other income expense net -0.08M -0.09M -0.04M -0.16M -
Net income applicable to common shares - - - - -0.48M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 0.27M 0.17M 0.19M 0.02M -
Intangible assets 0.07M 0.10M 0.14M - -
Other current assets 0.16M - 0.00M 0.00M -
Total liab 1.52M 1.22M 0.96M 0.72M -
Total stockholder equity -1.25M -1.05M -0.78M -0.71M -
Other current liab 0.45M 0.32M 0.32M 0.28M 0.02M
Common stock 37.40M 29.90M 18.10M 6.86M 5.58M
Retained earnings -21.14M -20.82M -20.45M -20.24M -19.47M
Other assets - - 0.00M - 0.00M
Cash 0.00M 0.01M 0.03M 0.00M -
Total current liabilities 0.75M 0.99M 0.45M 0.46M 0.50M
Current deferred revenue 0.01M - 0.01M - -
Net debt 0.85M 0.66M 0.56M 0.36M -
Short term debt 0.08M 0.44M 0.07M 0.10M -
Short long term debt total 0.85M 0.66M 0.58M 0.36M -
Other stockholder equity -17.10M -9.82M 1.96M 12.67M -
Property plant equipment - - - - 0.04M
Total current assets 0.18M 0.07M 0.05M 0.00M 0.14M
Net tangible assets - - - - -0.33M
Short term investments 0.00M - - - -
Net receivables 0.02M 0.06M 0.02M 0.00M 0.00M
Inventory - - -0.00M -0.00M 0.08M
Accounts payable 0.20M 0.23M 0.06M 0.08M 0.06M
Accumulated other comprehensive income -0.41M -0.31M -0.39M - -
Non currrent assets other - - -0.00M 0.00M -
Non current assets total 0.09M 0.10M 0.14M 0.01M -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Change to liabilities - - - - 0.00M
Total cashflows from investing activities -0.09M - - - -
Net borrowings - - - - 0.17M
Total cash from financing activities 0.14M 0.04M 0.13M 0.11M 0.27M
Change to operating activities - - - - 0.10M
Net income -0.33M -0.37M -0.21M -0.76M -0.48M
Change in cash -0.00M -0.02M 0.02M -0.07M 0.07M
Begin period cash flow 0.01M 0.03M 0.00M 0.07M -
End period cash flow 0.00M 0.01M 0.03M 0.00M -
Total cash from operating activities -0.06M -0.06M -0.11M -0.17M -0.20M
Depreciation 0.03M 0.06M 0.05M 0.08M -
Other cashflows from investing activities -0.07M - - - -
Change to inventory - - - 0.08M 0.00M
Change to account receivables 0.04M -0.03M -0.02M 0.00M -0.00M
Other cashflows from financing activities - - -0.00M - -
Change to netincome - - - - 0.12M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital 0.05M -0.03M 0.00M 0.18M -
Stock based compensation - 0.08M 0.01M 0.24M -
Other non cash items 0.18M 0.21M 0.05M 0.08M -
Free cash flow -0.06M -0.06M -0.11M -0.17M -

Peer Comparison*

Sector: Technology Industry: Software - Infrastructure

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
GSAC
GelStat Corp		 -
-%		 0.00 - - 22.67 - 221.46 -12.24
MSFT
Microsoft Corporation		 3.35
0.64%		 524.47 37.32 29.94 13.03 12.45 13.06 24.59
ORCL
Oracle Corporation		 -2.83
2.20%		 125.56 21.96 17.89 5.91 7.08 7.82 14.89
CRWD
Crowdstrike Holdings Inc		 -4.88
2.13%		 224.19 4849.80 188.68 46.01 47.24 43.89 559.34
FTNT
Fortinet Inc		 -0.67
0.52%		 127.43 60.27 43.86 16.80 80.50 16.11 43.33

Profile*

GelStat Corp

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation was founded in 2002 and is headquartered in Palm City, Florida.

3557 SW Corporate Parkway, Palm City, FL, United States, 34990

772 283 0020

https://www.gelstat.com

2

Name Title Year Born
Mr. Javier G. Acosta CEO & Director NA
Mr. Charles F. Tarzian Chief Marketing Advisor 1957
Dr. Roger K. Cady M.D. Chief Medical Advisor NA
Mr. Tim Sweeney Consultant of Branding & Marketing NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…